Licensing, Acquisitions and Other Arrangements (Details) - Pharmacyclics Inc $ / shares in Units, shares in Millions, $ in Millions	May. 26, 2015 USD ($) $ / shares shares
Collaborations and Other Arrangements
Percentage of cash consideration	58.00%
Percentage of share consideration	42.00%
Shares issued as consideration | shares	128
Cash consideration paid	$ 12,400
Fair value of AbbVie common stock issued to Pharmacyclics stockholders	8,405
Cash consideration paid to Pharmacyclics stockholders	11,749
Cash consideration paid to Pharmacyclics equity award holders	616
Total consideration	$ 20,770
Maximum period of valuation	1 year
Scenario One
Collaborations and Other Arrangements
Purchase price payment partly in cash (in dollars per share) | $ / shares	$ 152.25
Purchase price payment partly in fair market value of shares of acquirer's common stock (in dollars per share) | $ / shares	109.00
Scenario Two
Collaborations and Other Arrangements
Purchase price payment fully in cash (in dollars per share) | $ / shares	261.25
Scenario Three
Collaborations and Other Arrangements
Purchase price payment fully in fair market value of shares of acquirer's common stock (in dollars per share) | $ / shares	$ 261.25